Skip to main content

Books in Life sciences

Elsevier's Life Sciences collection helps researchers get comprehensive coverage and up-to-date information on the study of living organisms, their processes, and interrelationships, spanning disciplines like biology, genetics, and biochemistry, and addressing emerging trends such as genomics, biotechnology, and sustainability, essential for advancing knowledge and driving innovation in the field.

    • G Protein-Coupled Receptors - Part A

      • 1st Edition
      • Volume 193
      • November 8, 2022
      • English
      • Hardback
        9 7 8 0 3 2 3 9 9 4 3 1 6
      • eBook
        9 7 8 0 3 2 3 9 9 4 3 2 3
      G Protein-Coupled Receptors, Part A, Volume 193 in the Progress in Molecular Biology and Translational Science series, highlights new advances in the field. G protein-coupled receptors (GPCRs) represent the largest class of cell surface proteins with an intricate involvement of nearly every physiological process in our body. Approximately, one third of the clinically prescribed medicines target GPCRs and the quest to improve the exiting GPCR-targeting therapeutics continues. These two volumes are focused on activation, signaling and regulation of GPCRs with specific examples of receptor systems and cellular processes.
    • One, No one, One Hundred Thousand - The Multifaceted Role of Macrophages in Health and Disease - Part A

      • 1st Edition
      • Volume 367
      • April 20, 2022
      • English
      • Hardback
        9 7 8 0 3 2 3 9 0 7 4 1 5
      • eBook
        9 7 8 0 3 2 3 9 0 7 4 2 2
      One, No one, One Hundred Thousand - The Multifaceted Role of Macrophages in Health and Disease - Part A, provides in-depth reviews on the last progresses on the role of macrophages in health and diseases with a special focus on the role of macrophages in SARS-COV2, breast cancer, liver and salivary glands.
    • New Antibody Formats

      • 1st Edition
      • Volume 369
      • June 20, 2022
      • English
      • Hardback
        9 7 8 0 3 2 3 9 9 4 0 2 6
      • eBook
        9 7 8 0 3 2 3 9 9 4 1 0 1
      New Antibody Formats, Volume 369 in the International Review of Cell and Molecular Biology serial, highlights new advances in the field with this new volume presenting interesting chapters on a variety of important topics, including Current innovative engineered antibodies, Advances in bispecific antibodies, Applications of trimerbodies for cancer immunotherapy, Multispecific mAb-Anticalin formats, New antibody formats to treat Lung Cancer, Immunocytokines: from bench to bedside, and Single domain antibodies in cancer.
    • Methods in Stem Cell Biology - Part A

      • 1st Edition
      • Volume 170
      • July 7, 2022
      • English
      • Hardback
        9 7 8 0 3 2 3 9 0 0 2 0 1
      • eBook
        9 7 8 0 3 2 3 9 0 0 2 1 8
      Methods in Cancer Stem Cell Biology: Part A, Volume 170 in the Methods in Cell Biology series highlights advances in the field, with this new volume presenting interesting chapters on timely topics, including Orthotopic brain tumor models derived from glioblastoma stem-like cells, RNA sequencing in hematopoietic stem cells, Generation of inducible pluripotent stem cells from human dermal fibroblasts, In vitro preparation of dental pulp stem cell grafts combined with biocompatible scaffolds for tissue engineering, Gene expression knockdown in chronic myeloid leukemia stem cells, Identification and isolation of slow-cycling GSCs, Assessment of CD133, EpCAM, and much more.
    • Advances in Clinical Chemistry

      • 1st Edition
      • Volume 108
      • June 2, 2022
      • Gregory S. Makowski
      • English
      • Hardback
        9 7 8 0 3 2 3 9 8 8 4 9 0
      • eBook
        9 7 8 0 3 2 3 9 8 8 5 0 6
      Advances in Clinical Chemistry, Volume 108, the latest installment in this internationally acclaimed series, contains chapters authored by world-renowned clinical laboratory scientists, physicians and research scientists. The serial discusses the latest and most up-to-date technologies related to the field of clinical chemistry, with this new release focusing on Nephrinuria and podocytopathies, Extracellular vesicles in respiratory disease, Diabetes and cognitive decline, Testosterone analysis in prostate cancer, Mono/polyclonal free light chains as challenging biomarkers for immunological abnormalities, and more.
    • Recapitulating the Stem Cell Niche ex Vivo

      • 1st Edition
      • July 1, 2022
      • Susie Nilsson
      • English
      • Paperback
        9 7 8 0 3 2 3 9 1 0 9 1 0
      • eBook
        9 7 8 0 3 2 3 9 1 0 9 2 7
      Recapitulating The Stem Cell Niche Ex Vivo, Volume Six in the Advances in Stem Cells and their Niches series, highlights new advances in the field, with this new volume presenting interesting chapters on a variety of topics, including Recapitulating the bone marrow stem cell niche ex vivo, The generation of the liver ex vivo, Recapitulating the thymic stem cell niche ex vivo, Recapitulating the intestinal epithelium stem cell niche ex vivo, Recapitulating the lung stem cell niche in vitro, Recapitulating mammary tissue in vitro, and Recapitulating muscle in vitro.
    • Chemical Microbiology Part B

      • 1st Edition
      • Volume 665
      • April 2, 2022
      • English
      • Hardback
        9 7 8 0 3 2 3 9 5 2 6 7 5
      • eBook
        9 7 8 0 3 2 3 9 5 2 6 6 8
      Chemical Microbiology, Part B, Volume 665, the latest release in the Methods of Enzymology series, highlights new advances in the field, including comprehensive chapters on the Application of Antibiotic-derived Fluorescent Probes to Bacterial Studies, Metabolomic approaches for enzyme function and pathway discovery in bacteria, Adding a diazo-transfer reagent to culture to generate secondary metabolite probes for click chemistry, Customized Peptidoglycan Surfaces to Investigate Innate Immune Recognition via Surface Plasmon Resonance, Development and application of highly sensitive labeling reagents for amino acids, Bacterial Cell Wall Modification with a Glycolipid Substrate, and much more.
    • Conservation Physiology for the Anthropocene - A Systems Approach

      • 1st Edition
      • Volume 39A
      • October 17, 2022
      • English
      • Hardback
        9 7 8 0 1 2 8 2 4 2 6 6 7
      • eBook
        9 7 8 0 1 2 8 2 4 2 6 7 4
      Conservation Physiology for the Anthropocene: A Systems Approach, Volume 39A in the Fish Physiology series, is a comprehensive synthesis on the physiology of fish in the Anthropocene. This volume closes the knowledge gap by considering the many ways in which different physiological systems (e.g., sensory physiology, endocrine, cardio-respiratory, bioenergetics, water and ionic balance and homeostasis, locomotion/biomechan... gene function) and physiological diversity are relevant to management and conservation. As the world is changing, with a dire need to identify solutions to the many environmental problems facing wild fish populations, this book comprehensively covers conservation physiology and its future techniques. Conservation physiology reveals the many ways in which environmental change and human activities can negatively influence wild fish populations. These tactics inform new management and conservation activities and help create the necessary conditions for fish to thrive.
    • Hepatobiliary Cancers: Translational Advances and Molecular Medicine

      • 1st Edition
      • Volume 156
      • August 10, 2022
      • English
      • Hardback
        9 7 8 0 3 2 3 9 8 3 9 2 1
      • eBook
        9 7 8 0 3 2 3 9 8 3 9 3 8
      Hepatobiliary cancer refers to primary malignant tumors originating in cells of the liver, bile ducts, and gallbladder. Globally, primary liver cancer, which includes hepatocellular carcinoma (~75 % of all cases) and intrahepatic biliary cancer or cholangiocarcinoma (~10-15 % 0f all cases) is the 6th most commonly diagnosed cancer and 3rd leading cause of cancer deaths worldwide. The vast majority of these highly malignant cancers are diagnosed at an advanced stage where treatment options are limited and patient survival outcomes are poor. The biological and therapeutic challenges posed by hepatobililiary cancers such as hepatocellular carcinoma (HCC) and cholangiocarcinoma (CCA) are daunting, emphasizing a critical need to review and assess current and evolving basic, translational, and clinical research focused on addressing the critical obstacles that continue to limit progress towards achieving significant improvements in HCC and CCA clinical management and patient survival outcomes. Towards this goal, this special edition of Advances in Cancer Research is focused on providing a comprehensive, timely and authoritative reviews covering such topics of significant scientific and clinical relevance, including hepatobiliary cancer risk mechanisms and risk-predictive molecular biomarkers; causes and functional intricacies of inter- and intratumor heterogeneity; novel insights into the role of tumor microenvironment and key signaling pathways in promoting hepatobiliary cancer progression, therapeutic resistance and immunosuppression; emerging biomarkers of HCC and CCA prognosis; advances in molecular genomics for personalizing tumor classification and targeted therapies; innovative preclinical cell culture modeling for hepatobiliary cancer drug discovery; and current and emerging trends in hepatobiliary cancer molecular therapeutic targeting and immunotherapies.
    • Advances in Genetics

      • 1st Edition
      • Volume 110
      • October 13, 2022
      • English
      • Hardback
        9 7 8 0 4 4 3 1 8 8 7 8 7
      • eBook
        9 7 8 0 4 4 3 1 8 8 7 9 4
      Advances in Genetics serial, Volume 110 highlights new advances in the field, with this new volume presenting interesting chapters on a variety of timely topics, all written by an international board of authors.